In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.
COVID-19
cobicistat
drug hits
icatibant
main protease enzyme
nafarelin
Journal
Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
pubmed:
2
7
2020
medline:
18
8
2021
entrez:
2
7
2020
Statut:
ppublish
Résumé
The recent outbreak of the 2019 novel coronavirus disease (COVID-19) has been proved as a global threat. No particular drug or vaccine has not yet been discovered which may act specifically against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and causes COVID-19. For this highly infectious virus, 3CL-like main protease (3CL
Identifiants
pubmed: 32608329
doi: 10.1080/07391102.2020.1787228
doi:
Substances chimiques
Protease Inhibitors
0
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM